Publications | PubMed=16107020 Mikhailova I.N., Lukashina M.I., Baryshnikov A.Y., Morozova L.F., Burova O.S., Palkina T.N., Kozlov A.M., Golubeva V.A., Cheremushkin E.A., Doroshenko M.B., Demidov L.V., Kiselev S.L., Larin S.S., Georgiev G.P. Melanoma cell lines as the basis for antitumor vaccine preparation. Vestn. Ross. Akad. Med. Nauk 2005:37-40(2005) CLPUB00681 Berezhnoy A.E., Zakeyeva I.R., Kibardin A.V., Chernysheva A.D., Moiseyenko V.M., Danilov A.O., Demidov L.V., Baryshnikov A.Y., Gnuchev N.V., Georgiev G.P., Larin S.S. Analysis of HLA-E expression in human melanoma cells. Ross. Bioterap. Zh. 5:66-71(2006) Patent=RU2364624 Mikhailova I.N., Baryshnikov A.Y., Demidov L.V., Kiselev S.L., Burova O.S., Morozova L.F. Cell line of human melanoma mel Cher, used for obtaining anti-tumour vaccines. Patent number RU2364624, 20-Aug-2009 Patent=RU2404243 Grigorieva I.N., Stepanova E.V., Vartanjan A.A., Baryshnikov A.Y., Mikhailova I.N., Morozova L.F., Burova O.S. Application of human skin melanoma cell line mel Cher as positive model of vasculogenic mimicry. Patent number RU2404243, 20-Nov-2010 CLPUB00680 Mikhailova I.N., Baryshnikov A.Y., Morozova L.F., Burova O.S., Shubina I.Z., Kovalevsky D.A., Voronina E.S., Treshalina H.M., Lushnikova A.A., Tsyganova I.V., Mazurenko N.N. Human skin melanoma cell lines collection. (In) Management of malignant melanoma; pp.1-6; SM Group; Dover (2016) DOI=10.17650/1726-9784-2016-15-3-90-94 Morozova L.F., Suraeva N.M., Burova O.S., Barmashov A.E., Baryshnikova M.A. Changes in the morphological and immunological characteristics of Mel Cher melanoma cells in response to low concentration of embryo calf serum. Ross. Bioterap. Zh. 15:90-94(2016) PubMed=27313776; DOI=10.3892/ol.2016.4523 Vartanian A.A., Karshieva S., Dombrovsky V., Belyavsky A. Melanoma educates mesenchymal stromal cells towards vasculogenic mimicry. Oncol. Lett. 11:4264-4268(2016) PubMed=28881731; DOI=10.18632/oncotarget.17014 Emelyanova M., Ghukasyan L., Abramov I., Ryabaya O., Stepanova E.V., Kudryavtseva A., Sadritdinova A., Dzhumakova C., Belysheva T., Surzhikov S., Lyubchenko L., Zasedatelev A., Nasedkina T. Detection of BRAF, NRAS, KIT, GNAQ, GNA11 and MAP2K1/2 mutations in Russian melanoma patients using LNA PCR clamp and biochip analysis. Oncotarget 8:52304-52320(2017) DOI=10.17650/1726-9784-2018-17-4-27-35 Mikhailova I.N., Treshalina E.M., Morozova L.F., Andronova N.V., Shubina I.Z., Lushnikova A.A. Cell lines of human melanoma and their xenograft with BRAF or NRAS mutations a targets for targeted therapy. Ross. Bioterap. Zh. 17:27-35(2018) |